Drug Approval | October 05, 2023
Alembic received 6 USFDA approvals during Q2FY24
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
WINLEVI works differently from any other topical acne treatment
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The companies will work with investigators to share the results with the scientific community
Subscribe To Our Newsletter & Stay Updated
